Please use this identifier to cite or link to this item:
Title: Largest case series of Latin American eyelid tumors over 13-Years from a single center in Sao Paulo, Brazil
Authors: Damasceno, Jessica Carolinne
Isenberg, Jordan
Lopes, Laise Rondon
Hime, Bernardo
Fernandes, Bruno F.
Lowen, Marcia [UNIFESP]
Aranha Camargo, Luis Marcelo
Belfort, Rubens N. [UNIFESP]
Keywords: Eyelid neoplasms
Basal cell carcinoma
Squamous cell carcinoma
Issue Date: 2018
Publisher: Consel Brasil Oftalmologia
Citation: Arquivos Brasileiros De Oftalmologia. Sao Paulo, v. 81, n. 1, p. 7-11, 2018.
Abstract: Purpose: Malignant lesions of the eyelid are the most common eye cancers. Although rarely lethal, late diagnosis can lead to serious visual morbidity. Definitive diagnosis of neoplastic lesions is pathological. Indications and types of eyelid lesions in a single high-volume ophthalmic reference center in Sao Paulo, Brazil, were analyzed. Methods: The surgical pathological reports of patients who underwent eye removal procedures between January 2000 and December 2012 were retrieved from the electronic database of the Ophthalmology Department and retrospectively reviewed. Data regarding the final anatomopathological diagnosis, sex, and age were analyzed via the chi(2) test with Yates' correction. Results: Of the 1,113 eyelid tumors resected over the 13-year study period, 324 (29%) lesions were malignant. The most prevalent lesions were basal cell, squamous cell, and sebaceous gland carcinomas. The median ages of patients (females, n=165, 51%
males, n=159, 49%) with a diagnosis of basal cell, squamous cell, and sebaceous gland carcinomas were 65, 75, and 70 years, respectively. Conclusion: This is the largest retrospective cohort analysis of eyelid tumors in a Latin American population. These findings are in agreement with those from large centers in other countries and regions.
ISSN: 0004-2749
Other Identifiers:
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.